| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 07/31/2003 | WO2003002596A3 Use of dipeptidyl peptidase iv inhibitors as therapeutics for neurological disorders |
| 07/31/2003 | WO2002051410A3 Phenylthiazole and thiazoline derivatives and their use as antiparasitics |
| 07/31/2003 | WO2002020500A3 Materials and methods to potentiate cancer treatment |
| 07/31/2003 | US20030144542 Use of propargyl glycine amino propargyl diol compounds for treatment of renal failure |
| 07/31/2003 | US20030144526 Calcium receptor-active compounds |
| 07/31/2003 | US20030144523 Epothilone derivatives, method for producing same and their pharmaceutical use |
| 07/31/2003 | US20030144521 Hydrogenation of a corresponding nonracemic 1-(4-benzoxy phenyl)-2-(4-hydroxy-4- phenyl-piperidin-1-yl)-1-propanone using a catalyst system comprising ruthenium, a nonracemic diphosphine ligand, a bidentate amine ligand selected from |
| 07/31/2003 | US20030144331 p53 inhibitors and therapeutic use of the same |
| 07/31/2003 | US20030144329 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases |
| 07/31/2003 | US20030144323 Phenylalkynes |
| 07/31/2003 | US20030144288 Sulfur compounds such as 4-fluoro-N-(4-methoxy-7-(tetrahydro-pyran-4-yl)-benzothiazol-2-yl) -benzamide, used as preferential adenosine receptor ligands for the prophylaxis of neurodegenerative disorders |
| 07/31/2003 | US20030143633 Factors participating in degranulation of mast cells, dnas encoding the same, method of screening of these factors and the inhibitors |
| 07/31/2003 | CA2474322A1 4(hetero-) aryl substituted (thia-/oxa-/pyra) zoles for inhibition of tie-2 |
| 07/31/2003 | CA2471989A1 2-aminothiazole allosteric enhancers of a1 adenosine receptors |
| 07/31/2003 | CA2471389A1 Process for the preparation of nonracemic syn-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenyl-piperidin-1yl)-1-propanol compounds |
| 07/30/2003 | EP1331224A1 Thiazole or oxazole derivatives |
| 07/30/2003 | EP1331221A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 07/30/2003 | EP1330446A1 Process for the manufacture of thiazole derivatives with pesticidal activity |
| 07/30/2003 | EP1052989B1 Use of 2-amino-6- trifluoromehthoxy- benzothiazole for preventing or treating cerebellum dysfunction |
| 07/30/2003 | EP0991428B1 Delta1,2 bicyclo 4,4,0] functional dyes for contrast enhancement in optical imaging |
| 07/30/2003 | EP0958296B1 Heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| 07/30/2003 | CN1433415A N-[5-[[[5-alkyl-2-oxazlyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 07/30/2003 | CN1433414A Benzazole derivatives and their use as JNK modulators |
| 07/30/2003 | CN1433408A Aminothiazole inhibitors of cyslin dependent kinases |
| 07/30/2003 | CN1433297A Topical compositions comprising protected functional thiols |
| 07/30/2003 | CN1116288C Urea derivatives as inhibitors of inosine-5'-phospho-dehydrogenase |
| 07/29/2003 | US6600058 Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments |
| 07/29/2003 | US6600035 6-(substituted methylene) penems and intermediates |
| 07/29/2003 | US6599943 Preventive treatment, related to the radical generating nature of the xanthine dehydrogenase/xanthine oxidase |
| 07/29/2003 | US6599932 Highly selective in killing tumor cells but not normal cells |
| 07/29/2003 | US6599923 Insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action |
| 07/29/2003 | US6599910 Substituted triazole compounds |
| 07/29/2003 | US6599904 Sulphonamide derivatives, process for their preparation, and their use as medicaments |
| 07/29/2003 | US6599903 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 07/24/2003 | WO2003060078A2 Heterocyclic modulators of nuclear receptors |
| 07/24/2003 | WO2003059900A1 Coumarin derivatives, process for their production and use thereof |
| 07/24/2003 | WO2003059896A1 Method for producing halogenated 2-(3-butenylsulfanyl)-1,3-thiazoles |
| 07/24/2003 | WO2003059895A1 Halogenobenzyl aminopropionic acid derivatives |
| 07/24/2003 | WO2003059886A1 Acyl sulfonamide derivative |
| 07/24/2003 | WO2003059873A1 Potassium channel modulators |
| 07/24/2003 | WO2003059871A1 N-alkylsulfonyl-substituted amide derivatives |
| 07/24/2003 | WO2003059864A2 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 07/24/2003 | WO2003059265A2 Compositions and methods for treating heart failure |
| 07/24/2003 | WO2003059064A1 Insecticides containing hydrazone derivatives as the active ingredient and novel hydrazone derivatives |
| 07/24/2003 | US20030139473 Novel compounds, their preparation and use |
| 07/24/2003 | US20030139453 Difluorobutyric acid metalloprotease inhibitors |
| 07/24/2003 | US20030139449 Anxiolytic agents; psychological disorders; cognition activators |
| 07/24/2003 | US20030139405 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | US20030139404 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents |
| 07/24/2003 | US20030139390 Compounds for the modulation of PPARgamma activity |
| 07/24/2003 | US20030139379 Autoimmune disease, osteoporosis, rheumatic diseases, skin disorders |
| 07/24/2003 | CA2473207A1 Halogenobenzylaminopropionic acid derivatives |
| 07/24/2003 | CA2472419A1 Coumarin derivatives, process for their production and use thereof |
| 07/24/2003 | CA2472209A1 Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity |
| 07/23/2003 | EP1328271A2 Method for the treatment of neurological and neuropsychological disorders |
| 07/23/2003 | EP1328270A2 Method for the treatment of neurological and neuropsychological disorders |
| 07/23/2003 | EP1328265A2 Novel uses for thyroid hormones or thyroid hormone-like agonist compounds for treating dermis conditions |
| 07/23/2003 | EP0929528B1 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/23/2003 | EP0808163B1 Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts |
| 07/23/2003 | EP0695183B1 Use of thiazolidinediones for the treatment of atherosclerosis and eating disorders |
| 07/23/2003 | CN1432004A Alkynyl phenyl heteroaromatic glucokinase activators |
| 07/23/2003 | CN1431941A 挤压模 Extrusion die |
| 07/22/2003 | US6596875 Method for synthesizing epothilones and epothilone analogs |
| 07/22/2003 | US6596863 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
| 07/22/2003 | US6596754 Preventives/remedies for multiple organ failure |
| 07/22/2003 | US6596746 Cyclic protein tyrosine kinase inhibitors |
| 07/22/2003 | US6596744 Method for treating fibrotic diseases or other indications IIC |
| 07/22/2003 | US6596741 Compounds of formula I exhibit activity as serotonin, norepinephrine, and dopamine reuptake inhibitors and can be used in the treatment of central nervous system and other disorders. |
| 07/22/2003 | US6596718 7-Morpholin-4yl-benzothiazole amide derivatives |
| 07/22/2003 | US6596716 2-propane-sulphonamide derivatives |
| 07/22/2003 | US6596693 Dipeptide apoptosis inhibitors and the thereof |
| 07/17/2003 | WO2003057681A1 Process for producing 2-cyanoimino-1,3-thiazolidine |
| 07/17/2003 | WO2003057680A1 Process for producing 2-cyanoimino-1,3-thiazolidine |
| 07/17/2003 | WO2003057666A2 Inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057200A2 Compositions comprising inhibitors of dpp-iv and nep enzymes for the treatment of diabetes |
| 07/17/2003 | WO2003057169A2 4-dedimethylamino tetracycline compounds |
| 07/17/2003 | WO2003057144A2 Change inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003056922A1 Substituted thiazolyl sulfonyl urea compounds |
| 07/17/2003 | US20030135066 Renin inhibitors for the treatment of hypertension and glaucoma. |
| 07/17/2003 | US20030134885 Biaromatic ligand activators of PPARgamma receptors |
| 07/17/2003 | US20030134883 Use in the treatment of cancer and other diseases characterized by undesired cellular hyperproliferation. |
| 07/17/2003 | US20030134874 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/17/2003 | US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus |
| 07/17/2003 | US20030134857 Synergistic insecticide mixtures |
| 07/17/2003 | US20030134855 P-acylaminomethyl-N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2 -yl)-benzamides; treatment of diseases related to the adenosine receptor, such as Alzheimer's disease, depression, drug addiction, Parkinson's and ADHD |
| 07/17/2003 | US20030134848 Substituted 1-aza-2-imino-heterocycles and their use as nicotinic acetylcholin receptors activators |
| 07/17/2003 | US20030134802 Novel effectors of dipepetidyl peptidase IV |
| 07/17/2003 | US20030134237 Methine dyes, manufacturing methods thereof, and silver halide photoraphic materials contaning same dyes |
| 07/17/2003 | CA2471204A1 Inhibitors of dipeptidyl peptidase iv |
| 07/16/2003 | EP1327887A2 Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation end products |
| 07/16/2003 | EP1326861A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 07/16/2003 | EP1326852A1 Aromatic and heterocyclic thiazolyl thiourea compounds and use |
| 07/16/2003 | EP1326850A1 A process for the preparation of bis-benzazolyl compounds |
| 07/16/2003 | EP1326835A1 Benzamide compounds as apo b secretion inhibitors |
| 07/16/2003 | EP1326828A1 Beta-amino acid derivatives as integrin receptor antagonists |
| 07/16/2003 | EP1326824A1 Pharmaceutical compounds |
| 07/16/2003 | CN1430615A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/16/2003 | CN1430614A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/16/2003 | CN1430613A Method for producing 2-chloro-5-chloromethyl-1,3-thiazole |
| 07/16/2003 | CN1430612A Hete rocyclic derivatives |